キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/12/09 | 1,017 | 1,020 | 1,001 | 1,007 | -10 | -1% | 28,600 |
| 2013/12/06 | 1,045 | 1,068 | 1,002 | 1,017 | -14 | -1.4% | 41,700 |
| 2013/12/05 | 1,013 | 1,082 | 1,013 | 1,031 | +21 | +2.1% | 92,900 |
| 2013/12/04 | 1,016 | 1,028 | 1,010 | 1,010 | -5 | -0.5% | 48,200 |
| 2013/12/03 | 1,040 | 1,043 | 1,014 | 1,015 | +2 | +0.2% | 46,300 |
| 2013/12/02 | 1,027 | 1,029 | 1,009 | 1,013 | +9 | +0.9% | 21,300 |
| 2013/11/29 | 1,001 | 1,023 | 1,001 | 1,004 | -6 | -0.6% | 20,600 |
| 2013/11/28 | 1,022 | 1,027 | 1,003 | 1,010 | -16 | -1.6% | 24,800 |
| 2013/11/27 | 1,031 | 1,048 | 1,026 | 1,026 | -17 | -1.6% | 10,400 |
| 2013/11/26 | 1,001 | 1,050 | 1,001 | 1,043 | +16 | +1.6% | 31,100 |
| 2013/11/25 | 1,070 | 1,073 | 1,000 | 1,027 | -35 | -3.3% | 42,700 |
| 2013/11/22 | 1,081 | 1,090 | 1,050 | 1,062 | -19 | -1.8% | 33,800 |
| 2013/11/21 | 1,115 | 1,115 | 1,070 | 1,081 | -29 | -2.6% | 32,900 |
| 2013/11/20 | 1,114 | 1,120 | 1,093 | 1,110 | +7 | +0.6% | 36,900 |
| 2013/11/19 | 1,142 | 1,142 | 1,103 | 1,103 | -41 | -3.6% | 37,300 |
| 2013/11/18 | 1,165 | 1,170 | 1,141 | 1,144 | -8 | -0.7% | 19,900 |
| 2013/11/15 | 1,160 | 1,170 | 1,142 | 1,152 | -60 | -5% | 65,700 |
| 2013/11/14 | 1,165 | 1,226 | 1,165 | 1,212 | +49 | +4.2% | 31,400 |
| 2013/11/13 | 1,150 | 1,169 | 1,140 | 1,163 | +5 | +0.4% | 10,800 |
| 2013/11/12 | 1,130 | 1,176 | 1,100 | 1,158 | +23 | +2% | 14,700 |
| 2013/11/11 | 1,184 | 1,184 | 1,133 | 1,135 | -39 | -3.3% | 15,200 |
| 2013/11/08 | 1,177 | 1,184 | 1,148 | 1,174 | -10 | -0.8% | 13,800 |
| 2013/11/07 | 1,158 | 1,192 | 1,157 | 1,184 | -14 | -1.2% | 12,000 |
| 2013/11/06 | 1,221 | 1,225 | 1,185 | 1,198 | -53 | -4.2% | 11,800 |
| 2013/11/05 | 1,175 | 1,254 | 1,148 | 1,251 | +77 | +6.6% | 27,100 |
| 2013/11/01 | 1,192 | 1,228 | 1,111 | 1,174 | -57 | -4.6% | 41,200 |
| 2013/10/31 | 1,222 | 1,240 | 1,180 | 1,231 | -39 | -3.1% | 29,100 |
| 2013/10/30 | 1,349 | 1,349 | 1,224 | 1,270 | -51 | -3.9% | 38,400 |
| 2013/10/29 | 1,350 | 1,360 | 1,321 | 1,321 | -3 | -0.2% | 11,300 |
| 2013/10/28 | 1,372 | 1,379 | 1,290 | 1,324 | -33 | -2.4% | 24,100 |
| 2013/10/25 | 1,345 | 1,360 | 1,320 | 1,357 | +26 | +2% | 35,200 |
| 2013/10/24 | 1,290 | 1,332 | 1,283 | 1,331 | +21 | +1.6% | 22,800 |
| 2013/10/23 | 1,330 | 1,335 | 1,297 | 1,310 | -6 | -0.5% | 14,200 |
| 2013/10/22 | 1,342 | 1,350 | 1,307 | 1,316 | -28 | -2.1% | 25,500 |
| 2013/10/21 | 1,270 | 1,349 | 1,268 | 1,344 | +79 | +6.2% | 43,700 |
| 2013/10/18 | 1,236 | 1,288 | 1,236 | 1,265 | +10 | +0.8% | 13,600 |
| 2013/10/17 | 1,290 | 1,299 | 1,232 | 1,255 | -6 | -0.5% | 22,700 |
| 2013/10/16 | 1,284 | 1,294 | 1,252 | 1,261 | -50 | -3.8% | 25,400 |
| 2013/10/15 | 1,350 | 1,390 | 1,300 | 1,311 | -9 | -0.7% | 40,200 |
| 2013/10/11 | 1,290 | 1,390 | 1,250 | 1,320 | +120 | +10% | 78,000 |
| 2013/10/10 | 1,220 | 1,235 | 1,200 | 1,200 | -34 | -2.8% | 19,100 |
| 2013/10/09 | 1,148 | 1,235 | 1,148 | 1,234 | +26 | +2.2% | 20,300 |
| 2013/10/08 | 1,155 | 1,210 | 1,113 | 1,208 | +23 | +1.9% | 32,500 |
| 2013/10/07 | 1,230 | 1,250 | 1,181 | 1,185 | -67 | -5.4% | 33,300 |
| 2013/10/04 | 1,267 | 1,270 | 1,205 | 1,252 | -45 | -3.5% | 43,500 |
| 2013/10/03 | 1,277 | 1,310 | 1,260 | 1,297 | -2 | -0.2% | 37,900 |
| 2013/10/02 | 1,329 | 1,405 | 1,265 | 1,299 | -53 | -3.9% | 78,300 |
| 2013/10/01 | 1,484 | 1,510 | 1,352 | 1,352 | -48 | -3.4% | 118,700 |
| 2013/09/30 | 1,400 | 1,450 | 1,309 | 1,400 | +15 | +1.1% | 119,500 |
| 2013/09/27 | 1,243 | 1,500 | 1,208 | 1,385 | +148 | +12% | 223,300 |
2851～
2900
件表示中 / 3759件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 102,500円 | - | - | 0.00% | - | 6.77倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ミズホメディ | 149,500円 | -20.7% | -41.2% | 5.69% | 12.74倍 | 1.64倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 227,600円 | +1.6% | -12.7% | 3.95% | 8.45倍 | 0.59倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 31,700円 | - | - | 0.00% | - | 2.92倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| ラクオリア | 63,100円 | +25.1% | - | 0.00% | - | 2.78倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム
